UNSPSC 85322901: Diagnosis of haemophagocytic lymphohistiocytosis

This classification denotes the group of activities that yields a diagnosis of Haemophagocytic lymphohistiocytosis. Haemophagocytic lymphohistiocytosis is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D76. 1

UNSPSC 85322901 Diagnosis of haemophagocytic lymphohistiocytosis is a Commodity code that shows minimal alignment with actual state and local procurement activity. The three recent opportunities posted under this code span diagnostic imaging systems, special education contracted services, and temporary health professional staffing—none of which directly match the specialized hematologic diagnostic scope the code name describes. The diagnostic imaging opportunity from San Mateo Medical Center concerns PACS implementation and radiology system migration rather than haemophagocytic lymphohistiocytosis diagnosis; the school district solicitation covers speech, occupational, physical, and behavioral therapies with no connection to the code's clinical domain; and the Santa Clara Health System staffing vehicle solicits temporary placements across audiology, cardiology, gastroenterology, and other ancillary services, similarly unrelated to the code's narrow clinical focus. This pattern suggests the code has been applied to these opportunities as a catch-all category or administrative error rather than a meaningful taxonomic match.

The issuing bodies across these three records include a county hospital system, an independent school district, and a regional health system, indicating use across different public health and education segments. Geographic activity appears concentrated in California (San Mateo County and Santa Clara County) and Texas (Tarrant County), though the sample is too limited to characterize broader regional strength. Vendors pursuing work under this code should verify that actual solicitations align with their clinical or service capabilities before investment in pursuit, as the code's nominal scope does not reliably predict the buying activity posted beneath it.